A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Clinical trial NCT04111172 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04111172
Sponsor: Thomas Jefferson University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Colorectal Adenocarcinoma Gastric Adenocarcinoma Clinical Stage II Gastric Cancer AJCC v8 Clinical Stage IIA Gastric Cancer AJCC v8 Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 Clinical Stage IIB Gastric Cancer AJCC v8 Clinical Stage III Esophageal Adenocarcinoma AJCC v8 Clinical Stage III Gastric Cancer AJCC v8 Malignant Solid Neoplasm Pathologic Stage II Gastric Cancer AJCC v8 Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8

Start date: 2020-11-10
Primary completion: 2026-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.